These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1551276)

  • 1. Differential ability of wild-type and vaccine strains of rubella virus to replicate and persist in human joint tissue.
    Miki NP; Chantler JK
    Clin Exp Rheumatol; 1992; 10(1):3-12. PubMed ID: 1551276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rubella virus strain differences associated with attenuation.
    Chantler JK; Lund KD; Miki NP; Berkowitz CA; Tai G
    Intervirology; 1993; 36(4):225-36. PubMed ID: 8169114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells.
    Perelygina L; Adebayo A; Metcalfe M; Icenogle J
    PLoS One; 2015; 10(7):e0133267. PubMed ID: 26177032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of genetic determinants of rubella virus associated with growth in joint tissue.
    Lund KD; Chantler JK
    J Virol; 2000 Jan; 74(2):796-804. PubMed ID: 10623741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Japanese rubella vaccine: comparative trials.
    Best JM; Banatvala JE; Bowen JM
    Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women.
    Tingle AJ; Mitchell LA; Grace M; Middleton P; Mathias R; MacWilliam L; Chalmers A
    Lancet; 1997 May; 349(9061):1277-81. PubMed ID: 9142061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted mumps virus infection of cells derived from normal human joint tissue.
    Huppertz HI; Chantler JK
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():339-47. PubMed ID: 1993874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent rubella virus infection of human synovial cells cultured in vitro.
    Cunningham AL; Fraser JR
    J Infect Dis; 1985 Apr; 151(4):638-45. PubMed ID: 3973414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.
    Tingle AJ; Allen M; Petty RE; Kettyls GD; Chantler JK
    Ann Rheum Dis; 1986 Feb; 45(2):110-4. PubMed ID: 3947141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the full genetic information of Japanese rubella vaccines and the genetic changes associated with in vitro and in vivo vaccine virus phenotypes.
    Otsuki N; Abo H; Kubota T; Mori Y; Umino Y; Okamoto K; Takeda M; Komase K
    Vaccine; 2011 Feb; 29(10):1863-73. PubMed ID: 21251900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls.
    Menser MA; Forrest JM; Bransby RD; Collins E
    Med J Aust; 1978 Jul; 2(3):85-8. PubMed ID: 362141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of normal human joint tissue to viruses.
    Huppertz HI; Niki NP; Chantler JK
    J Rheumatol; 1991 May; 18(5):699-704. PubMed ID: 1650840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubella virus: mechanism of attenuation in the vaccine strain (HPV77).
    Nakhasi HL; Zheng D; Callahan L; Dave JR; Liu TY
    Virus Res; 1989 Jul; 13(3):231-43. PubMed ID: 2773598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent rubella infection and rubella-associated arthritis.
    Chantler JK; Ford DK; Tingle AJ
    Lancet; 1982 Jun; 1(8285):1323-5. PubMed ID: 6123637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of rubella virus vaccine TO-336 strain occurred in the attenuation process of wild progenitor virus.
    Kakizawa J; Nitta Y; Yamashita T; Ushijima H; Katow S
    Vaccine; 2001 Apr; 19(20-22):2793-802. PubMed ID: 11282189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction by the Therien and vaccine RA27/3 strains of rubella virus causes depletion of oligodendrocytes from rat neural cell cultures.
    Domegan LM; Atkins GJ
    J Gen Virol; 2002 Sep; 83(Pt 9):2135-2143. PubMed ID: 12185266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic sequence of the RA27/3 vaccine strain of rubella virus.
    Pugachev KV; Abernathy ES; Frey TK
    Arch Virol; 1997; 142(6):1165-80. PubMed ID: 9229006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination.
    Chantler JK; Ford DK; Tingle AJ
    Infect Immun; 1981 Jun; 32(3):1274-80. PubMed ID: 7019092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens and responses to rubella vaccination.
    Harcourt GC; Best JM; Banatvala JE; Kennedy LA
    J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.